URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Sandra McDonald

Concepts (176)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Biological Specimen Banks
2
2011
6
1.690
Why?
Carcinoma, Non-Small-Cell Lung
5
1993
71
0.900
Why?
Genomics
1
2012
48
0.830
Why?
Individualized Medicine
1
2011
5
0.820
Why?
Lung Neoplasms
7
1987
428
0.710
Why?
Lung
6
1989
1142
0.500
Why?
Head and Neck Neoplasms
4
1987
84
0.470
Why?
Interferon-beta
2
1993
63
0.440
Why?
Radiotherapy
2
1988
198
0.260
Why?
Radiotherapy Dosage
5
1987
203
0.260
Why?
Amifostine
1
1994
28
0.250
Why?
Salivary Glands
1
1994
63
0.240
Why?
Radiation Injuries
2
1988
130
0.240
Why?
Aryl Hydrocarbon Hydroxylases
1
2013
24
0.230
Why?
Humans
19
1987
36400
0.220
Why?
Genetic Research
1
2012
1
0.220
Why?
Aromatase
1
2012
3
0.220
Why?
Aromatase Inhibitors
1
2012
4
0.220
Why?
Pulmonary Fibrosis
2
1989
140
0.220
Why?
Alleles
1
2013
202
0.210
Why?
Ethics Committees, Research
1
2012
17
0.210
Why?
Genome, Human
1
2012
30
0.210
Why?
Information Dissemination
1
2012
24
0.210
Why?
RNA Splicing
1
2013
141
0.200
Why?
Informed Consent
1
2011
82
0.200
Why?
Quality Assurance, Health Care
1
2012
119
0.190
Why?
Pneumonia
2
1989
195
0.190
Why?
Carcinoma, Squamous Cell
2
1987
232
0.190
Why?
Physician's Role
1
2011
132
0.180
Why?
Drug Resistance, Neoplasm
1
2010
56
0.180
Why?
Laryngeal Neoplasms
1
1989
19
0.180
Why?
Neoplasms, Multiple Primary
1
1989
43
0.170
Why?
Insulin-Like Growth Factor I
1
2010
106
0.170
Why?
Cisplatin
2
1987
94
0.170
Why?
Smoking
1
2012
390
0.160
Why?
Neoplasm Metastasis
1
1987
229
0.140
Why?
Combined Modality Therapy
3
1987
486
0.140
Why?
Antibodies, Monoclonal
1
2010
732
0.140
Why?
Breast Neoplasms
1
2012
675
0.130
Why?
Radiation Pneumonitis
2
1995
44
0.130
Why?
Cystadenocarcinoma, Serous
1
2004
6
0.130
Why?
Cystadenocarcinoma, Papillary
1
2004
10
0.130
Why?
Adenocarcinoma, Clear Cell
1
2004
10
0.130
Why?
Dose-Response Relationship, Radiation
3
1989
218
0.120
Why?
Endometrial Neoplasms
1
2004
37
0.120
Why?
Brachytherapy
1
2004
111
0.120
Why?
Prognosis
4
1987
1080
0.110
Why?
Female
12
1987
19826
0.110
Why?
Exons
2
2012
163
0.100
Why?
Radiation Tolerance
2
1989
89
0.100
Why?
Survival Rate
2
1993
619
0.100
Why?
Neoplasms
1
1987
723
0.090
Why?
Recombinant Proteins
2
1993
768
0.090
Why?
Pilot Projects
2
1987
441
0.090
Why?
Pulmonary Surfactants
2
1989
250
0.090
Why?
Male
8
1988
19713
0.080
Why?
Middle Aged
6
1987
9877
0.080
Why?
Aged, 80 and over
3
1989
2513
0.070
Why?
Feasibility Studies
2
1992
205
0.070
Why?
Radiation Dosage
2
1993
126
0.070
Why?
Aged
5
1989
7272
0.070
Why?
Retrospective Studies
4
1994
2260
0.070
Why?
Antineoplastic Agents
2
2010
625
0.070
Why?
Respiratory Function Tests
1
1995
122
0.060
Why?
Clinical Protocols
1
1995
105
0.060
Why?
Fatigue
1
1996
125
0.060
Why?
Adult
5
1987
11345
0.060
Why?
Sodium Pertechnetate Tc 99m
1
1994
9
0.060
Why?
Secretory Rate
1
1994
42
0.060
Why?
Bronchoalveolar Lavage Fluid
2
1989
301
0.060
Why?
Radiation Protection
1
1994
23
0.060
Why?
Time Factors
2
1987
3201
0.060
Why?
DNA, Neoplasm
1
1994
123
0.060
Why?
Parotid Gland
1
1994
81
0.060
Why?
Antigens, Neoplasm
1
1994
107
0.060
Why?
Procollagen
1
1993
11
0.060
Why?
Follow-Up Studies
2
1987
1857
0.060
Why?
Cesium Radioisotopes
1
1993
29
0.060
Why?
Real-Time Polymerase Chain Reaction
1
2013
26
0.060
Why?
INDEL Mutation
1
2012
1
0.060
Why?
Radiation-Protective Agents
1
1993
41
0.050
Why?
High-Throughput Nucleotide Sequencing
1
2012
6
0.050
Why?
Exome
1
2012
2
0.050
Why?
Radiation-Sensitizing Agents
1
1993
72
0.050
Why?
Genome-Wide Association Study
1
2012
23
0.050
Why?
MAP Kinase Kinase Kinase 1
1
2012
9
0.050
Why?
MAP Kinase Kinase 4
1
2012
27
0.050
Why?
Molecular Targeted Therapy
1
2012
20
0.050
Why?
Mice, Inbred Strains
1
1993
242
0.050
Why?
Nitriles
1
2012
40
0.050
Why?
Androstadienes
1
2012
41
0.050
Why?
Respiration
1
1993
181
0.050
Why?
Microcomputers
1
1992
10
0.050
Why?
Evaluation Studies as Topic
2
1987
243
0.050
Why?
Mice
3
1993
6103
0.050
Why?
Animals
5
1989
16270
0.050
Why?
Radiotherapy, Computer-Assisted
1
1992
15
0.050
Why?
Chromosome Aberrations
1
2012
116
0.050
Why?
Triazoles
1
2012
39
0.050
Why?
Antineoplastic Combined Chemotherapy Protocols
1
1996
430
0.050
Why?
Phospholipids
1
1993
192
0.050
Why?
Genetic Variation
1
2012
148
0.050
Why?
DNA Primers
1
2013
414
0.050
Why?
Cytokines
1
1995
572
0.050
Why?
Point Mutation
1
2012
175
0.050
Why?
Medical Oncology
1
1992
49
0.050
Why?
Receptors, Estrogen
1
2012
180
0.050
Why?
Sensitivity and Specificity
1
1994
905
0.050
Why?
Clinical Trials, Phase II as Topic
1
2010
14
0.050
Why?
Severity of Illness Index
1
1995
919
0.050
Why?
Clinical Trials as Topic
1
1994
675
0.050
Why?
DNA Repair
1
2012
174
0.050
Why?
NIH 3T3 Cells
1
2010
24
0.050
Why?
Tissue Array Analysis
1
2010
35
0.050
Why?
Molecular Diagnostic Techniques
1
2010
11
0.050
Why?
Nuclear Proteins
1
1994
330
0.050
Why?
Immunoglobulins, Intravenous
1
2010
36
0.050
Why?
Hormone Antagonists
1
2010
43
0.050
Why?
Gene Expression Profiling
1
2012
299
0.040
Why?
Pulmonary Surfactant-Associated Proteins
1
1989
27
0.040
Why?
Apoproteins
1
1989
26
0.040
Why?
Radiation Injuries, Experimental
1
1989
88
0.040
Why?
Base Sequence
1
2013
1704
0.040
Why?
Whole-Body Irradiation
1
1989
82
0.040
Why?
Liver
1
2013
876
0.040
Why?
Treatment Outcome
2
1996
2623
0.040
Why?
Radioisotope Teletherapy
1
1987
4
0.040
Why?
Cobalt Radioisotopes
1
1987
17
0.040
Why?
Thoracic Neoplasms
1
1987
19
0.040
Why?
Colorectal Neoplasms
1
1989
136
0.040
Why?
Internship and Residency
1
1992
328
0.040
Why?
Infusions, Intravenous
1
1987
139
0.040
Why?
Lymphatic Metastasis
1
1987
136
0.040
Why?
Mutation
1
2012
1229
0.030
Why?
Palliative Care
1
1987
159
0.030
Why?
Brain Neoplasms
1
1988
282
0.030
Why?
Iridium Radioisotopes
1
2004
15
0.030
Why?
Radiopharmaceuticals
1
2004
49
0.030
Why?
Tomography, X-Ray Computed
1
1988
765
0.030
Why?
Disease-Free Survival
1
2004
202
0.030
Why?
Prostatic Neoplasms
1
1989
556
0.030
Why?
Neoplasm Staging
1
2004
335
0.030
Why?
Magnetic Resonance Imaging
1
1988
1010
0.030
Why?
United States
1
1989
2630
0.020
Why?
Brain
1
1988
1221
0.020
Why?
Adolescent
1
1987
4752
0.020
Why?
Etoposide
1
1996
83
0.020
Why?
Radiotherapy, Adjuvant
1
1996
73
0.020
Why?
Chemotherapy, Adjuvant
1
1996
88
0.020
Why?
Antineoplastic Agents, Phytogenic
1
1996
39
0.020
Why?
Treatment Failure
1
1996
130
0.020
Why?
Administration, Oral
1
1996
309
0.020
Why?
Drug Administration Schedule
1
1996
369
0.020
Why?
Platelet-Derived Growth Factor
1
1995
115
0.020
Why?
Ploidies
1
1994
18
0.020
Why?
Autoantigens
1
1994
34
0.020
Why?
Proliferating Cell Nuclear Antigen
1
1994
47
0.020
Why?
Interleukin-1
1
1995
222
0.020
Why?
Fibronectins
1
1995
152
0.010
Why?
Fluorescent Antibody Technique
1
1994
291
0.010
Why?
Collagen
1
1995
299
0.010
Why?
Survival Analysis
1
1996
598
0.010
Why?
Disease Progression
1
1996
519
0.010
Why?
Biopsy
1
1994
359
0.010
Why?
Transforming Growth Factor beta
1
1995
413
0.010
Why?
Predictive Value of Tests
1
1994
601
0.010
Why?
Computer Graphics
1
1992
19
0.010
Why?
Computer-Assisted Instruction
1
1992
20
0.010
Why?
Flow Cytometry
1
1994
597
0.010
Why?
Analysis of Variance
1
1994
725
0.010
Why?
Depression
1
1996
431
0.010
Why?
Mice, Inbred C57BL
1
1995
1683
0.010
Why?
Astrocytoma
1
1988
30
0.010
Why?
Glioblastoma
1
1988
63
0.010
Why?
Rabbits
1
1989
704
0.010
Why?
Biological Markers
1
1989
564
0.010
Why?

Visualizations


McDonald's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department